INVO Fertility, Inc (NASDAQ:IVF) Sees Large Decline in Short Interest

INVO Fertility, Inc (NASDAQ:IVF) was the recipient of a large decline in short interest in March. As of March 13th, there was short interest totaling 333,878 shares, a decline of 37.4% from the February 26th total of 533,091 shares. Based on an average daily volume of 257,577 shares, the days-to-cover ratio is currently 1.3 days. Currently, 4.8% of the company’s stock are sold short.

Institutional Trading of INVO Fertility

An institutional investor recently bought a new position in INVO Fertility stock. Citadel Advisors LLC purchased a new position in shares of INVO Fertility, Inc (NASDAQ:IVF) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned about 1.19% of INVO Fertility as of its most recent SEC filing. Institutional investors and hedge funds own 12.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on IVF. Wall Street Zen upgraded INVO Fertility from a “sell” rating to a “hold” rating in a report on Saturday, March 7th. Maxim Group set a $20.00 price objective on INVO Fertility in a research report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, INVO Fertility presently has an average rating of “Moderate Buy” and a consensus price target of $20.00.

INVO Fertility Price Performance

Shares of NASDAQ:IVF traded down $0.21 during trading on Friday, hitting $2.68. 233,012 shares of the company were exchanged, compared to its average volume of 52,537. The firm’s 50 day moving average price is $5.23 and its 200-day moving average price is $14.07. The stock has a market capitalization of $4.34 million, a P/E ratio of 0.00 and a beta of 2.66. INVO Fertility has a 12-month low of $2.56 and a 12-month high of $384.00.

About INVO Fertility

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.